Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2466
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia ; volume:22 ; number:1 ; day:28 ; month:11 ; year:2022 ; pages:1-10 ; date:12.2022
BMC pulmonary medicine ; 22, Heft 1 (28.11.2022), 1-10, 12.2022
- Creator
-
Torres-Duque, Carlos A.
Ocampo-Gómez, Jaime
Castillo, Mauricio Morales
Cano-Rosales, Diana
Giraldo-Montoya, Ángela
Rodríguez, Freddy
Palacios-Ortega, Isabel
Durán-Silva, Mauricio
Reynales, Humberto
García, Elizabeth
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12890-022-02246-x
- URN
-
urn:nbn:de:101:1-2023021110053320889040
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Torres-Duque, Carlos A.
- Ocampo-Gómez, Jaime
- Castillo, Mauricio Morales
- Cano-Rosales, Diana
- Giraldo-Montoya, Ángela
- Rodríguez, Freddy
- Palacios-Ortega, Isabel
- Durán-Silva, Mauricio
- Reynales, Humberto
- García, Elizabeth
- SpringerLink (Online service)
Other Objects (12)
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
Reduction in oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma receiving omalizumab in a real-world setting
Severe asthma and the omalizumab option
Poster 1012: Safety and efficacy of omalizumab in 10 children with asthma and other allergic comorbidities
Follicular T Helper and Breg Cell Balance in Severe Allergic Asthma Before and After Omalizumab Therapy
Omalizumab in the treatment of severe allergic (IgE-mediated) asthma: an update on recent developments
Omalizumab in children with severe allergic disease: a case series
Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study
Population-Based Pharmacodynamic Modeling of Omalizumab in Pediatric Patients with Moderate to Severe Persistent Inadequately Controlled Allergic Asthma
Effectiveness of the Polish program for the treatment of severe allergic asthma with omalizumab: a single-center experience
Poster 1014: Omalizumab efficiency in patients with allergic rhinitis and chronic sinusitis
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
Reduction in oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma receiving omalizumab in a real-world setting
Severe asthma and the omalizumab option
Poster 1012: Safety and efficacy of omalizumab in 10 children with asthma and other allergic comorbidities
Follicular T Helper and Breg Cell Balance in Severe Allergic Asthma Before and After Omalizumab Therapy
Omalizumab in the treatment of severe allergic (IgE-mediated) asthma: an update on recent developments
Omalizumab in children with severe allergic disease: a case series
Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study
Population-Based Pharmacodynamic Modeling of Omalizumab in Pediatric Patients with Moderate to Severe Persistent Inadequately Controlled Allergic Asthma
Effectiveness of the Polish program for the treatment of severe allergic asthma with omalizumab: a single-center experience
Poster 1014: Omalizumab efficiency in patients with allergic rhinitis and chronic sinusitis
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
Reduction in oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma receiving omalizumab in a real-world setting
Severe asthma and the omalizumab option
Poster 1012: Safety and efficacy of omalizumab in 10 children with asthma and other allergic comorbidities
Follicular T Helper and Breg Cell Balance in Severe Allergic Asthma Before and After Omalizumab Therapy
Omalizumab in the treatment of severe allergic (IgE-mediated) asthma: an update on recent developments
Omalizumab in children with severe allergic disease: a case series
Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study
Population-Based Pharmacodynamic Modeling of Omalizumab in Pediatric Patients with Moderate to Severe Persistent Inadequately Controlled Allergic Asthma
Effectiveness of the Polish program for the treatment of severe allergic asthma with omalizumab: a single-center experience